Microbix Enterprise Value Multiple from 2010 to 2026

MBX Stock  CAD 0.23  0.01  4.55%   
Microbix Biosystems Enterprise Value Multiple yearly trend continues to be very stable with very little volatility. Enterprise Value Multiple is likely to grow to 88.93 this year. During the period from 2010 to 2026, Microbix Biosystems Enterprise Value Multiple quarterly data regression pattern had sample variance of  1,820 and median of  17.97. View All Fundamentals
 
Enterprise Value Multiple  
First Reported
2010-12-31
Previous Quarter
84.69
Current Value
88.93
Quarterly Volatility
42.66395595
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Microbix Biosystems financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Microbix Biosystems' main balance sheet or income statement drivers, such as Depreciation And Amortization of 2.1 M, Interest Expense of 560.6 K or Selling General Administrative of 11 M, as well as many indicators such as Price To Sales Ratio of 2.17, Dividend Yield of 1.97 or PTB Ratio of 1.45. Microbix financial statements analysis is a perfect complement when working with Microbix Biosystems Valuation or Volatility modules.
  
This module can also supplement various Microbix Biosystems Technical models . Check out the analysis of Microbix Biosystems Correlation against competitors.
Evaluating Microbix Biosystems's Enterprise Value Multiple across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Microbix Biosystems's fundamental strength.

Latest Microbix Biosystems' Enterprise Value Multiple Growth Pattern

Below is the plot of the Enterprise Value Multiple of Microbix Biosystems over the last few years. It is Microbix Biosystems' Enterprise Value Multiple historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Microbix Biosystems' overall financial position and show how it may be relating to other accounts over time.
Enterprise Value Multiple10 Years Trend
Pretty Stable
   Enterprise Value Multiple   
       Timeline  

Microbix Enterprise Value Multiple Regression Statistics

Arithmetic Mean29.05
Geometric Mean22.31
Coefficient Of Variation146.86
Mean Deviation31.64
Median17.97
Standard Deviation42.66
Sample Variance1,820
Range159
R-Value0.18
Mean Square Error1,879
R-Squared0.03
Significance0.49
Slope1.51
Total Sum of Squares29,123

Microbix Enterprise Value Multiple History

2026 88.93
2025 84.69
2024 73.65
2023 6.32
2022 19.31
2021 16.46
2020 12.39

About Microbix Biosystems Financial Statements

Microbix Biosystems investors utilize fundamental indicators, such as Enterprise Value Multiple, to predict how Microbix Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Enterprise Value Multiple 84.69  88.93 

Other Information on Investing in Microbix Stock

Microbix Biosystems financial ratios help investors to determine whether Microbix Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Microbix with respect to the benefits of owning Microbix Biosystems security.